Cell therapy is a potentially powerful tool in the treatment of many grave disorders including leukemia, immune deficiencies, autoimmune diseases, and diabetes. However, finding matched donors is challenging and recipients may suffer from the severe complications of systemic immune suppression. Sertoli cells, when cotransplanted with both allo-and xenograft tissues, promote graft acceptance in the absence of systemic immunosuppression. How Sertoli cells do this is not, as yet, clearly defined. We have examined the ability of Sertoli cells to produce systemic immune tolerance. For this purpose, Sertoli cells were injected into an otherwise normal C57/BL6 mouse host via the lateral tail vein. No other immunosuppressive protocols were applied. Six to 8 weeks posttransplantation, blood was collected for analysis of cytokine levels. Tolerance to donor cells was determined by mixed lymphocytic culture, and production of T-cell-dependent antibody was determined by an in vitro anti-sheep red blood cell plaque-forming assay. Results showed a marked modulation of immune cytokines in the transplanted mouse host and donor-specific transplantation tolerance was achieved. Tolerant mouse lymphocytes maintained a competent humoral antibody response. Additionally, C57/BL6 mice transplanted with rat Sertoli cells tolerated rat skin grafts significantly longer than control non-Sertoli cell transplanted mice. We conclude that systemic administration of rat Sertoli cells across xenogenic barrier induces transplantation tolerance without altering systemic immune competence. These data suggest that Sertoli cells may be used as a novel and potentially powerful tool in cell transplantation therapy. 45 46 SHAMEKH ET AL. system. It is now known, however, that antigenic germ
INTRODUCTION
their practical use as clinically relevant therapeutic protocols is unlikely because most immunosuppressing protocols cause severe side effects incompatible with a nor-Cell transplantation therapy is a potentially powerful tool in the treatment of diseases for which there are cur-mal lifestyle (14, 19) . Sertoli cells are a permanent population of cells rently no practical cures. Theoretically, the replacement of defective cells by healthy cells offers the possibility found in mammalian testes that, in the adult, are terminally differentiated. They provide a dynamic trophic fac-of alleviating the devastating symptoms for many such diseases, including Parkinson's disease, stroke, Alzhei-tor-rich microenvironment for developing spermatids in a sequestered testicular compartment devoid of blood mer's disease, spinal cord injury, type 1 diabetes, cirrhosis of the liver, and factor 8 hemophilia. The success of and lymphatic vasculature, and play an essential role in preventing individuals from rejecting their own highly the "Edmonton protocol," which resulted in a 100% cure rate for human type 1 diabetes following the transplanta-antigenic mature germ cells (23) . The mechanism by which Sertoli cells impart immunoprotection to the ma-tion of islet allografts (35) , attests to this attractive potential. Clearly, allo-and xenografted cells can restore ture germ cells was thought to be the consequence of an elaborate network of Sertoli-Sertoli junctional com-function to dysfunctional tissues in experimental animal models of disease (12) . However, as long as these proto-plexes, the so-called "blood-testis barrier," that physically sequestered these cells from the systemic immune cols require persistent systemic immunosuppression, Instead, the secondary transplants resulted in a hyperimmune response and islet rejection. Since then, little re-cells reside outside of the blood-testis barrier but avoid rejection, undoubtedly by Sertoli cell secretory factors search has been directed toward elucidating the effects of transplanted isolated Sertoli cells on the systemic im-that immunoprotect these germ cells that reside on the systemic side of the blood-testis barrier (46). mune system, and the mechanism(s) by which these testis-derived cells result in immunoprotection of cotrans-On this basis and following the early observations of Selawry and Cameron (33, 34) , who showed that isolated planted cells and tissues remains unclear. The current study was designed to investigate the ef-Sertoli cells can create a testis-like immune privileged site outside of the testis, isolated Sertoli cells have been fect of systemic intravenous transplantation of isolated Sertoli cells, derived from the rat, on the induction of utilized in a number of cell allo-and xenograft cell transplantation protocols [for review see (12, 15) ]. The two donor-specific transplantation tolerance in the mouse by in vitro and in vivo assay. most studied areas for the transplantation application of isolated Sertoli cells have been with experimental models of diabetes (17, 18, 33, 35, 37, 41, 43) and neurodegen-MATERIALS AND METHODS erative diseases of the central nervous system (4,5,12, In Vitro Study 21,24,25,27-32, [38] [39] [40] . It is clear from these and other Animals. Forty 6-8-week-old male C57/BL6 (H-2b) reports that the cotransplantation of isolated Sertoli cells mice and eight Balb/C male mice (H-2d) (Harlan Laboprovides substantial trophic support to cells and tissue ratories and Jackson Laboratories), weighing 20-25 g grafts, and also reduces the likelihood of both allo-and at the time of surgery, were used in these experiments. xenograft rejection, even in the absence of systemic im-Sprague-Dawley rats were used to isolate Sertoli cells munosuppression (15,31). It is not yet clear, however, (SC) and peritubular cells (PTC) and to harvest normal how extratesticular Sertoli cells immunoprotect cell and spleens. All animals were routinely housed with free actissue grafts, although a number of theories have been cess to food and water in a temperature-controlled room offered (12, 15, 38) . In general, the ability of isolated Seron a 12:12-h light cycle. At 6-8 weeks following cell toli cells to cause a significant reduction or even elimitransplantation, experimental and control mice were eunation of allo-or xenograft rejection appears to be rethanized using CO 2 inhalation. This and all animal prolated to their close proximity to the cotransplanted cells cedures were completed according to guidelines estaband tissues, because most of the transplantation protolished and approved by the University of South Florida cols using isolated Sertoli cells have been performed by College of Medicine Institutional Animal Care and Use cotransplantation or coencapsulation of the cells. This Committee. has prompted the suggestion that Sertoli cells provide for "local immunosuppression" at the graft site (5-Cell Preparation. Testes from 15-17-day-old male Sprague-Dawley rats (Harlan Laboratories) were used to 7, 12, 15, 17, 18, 28, 33, 39, 40, 43, 44) .The possibility, however, that isolated Sertoli cells may impart their "immu-isolate both SC and PTC. The tunica albuginea was removed from each testes; the testicular parenchyma was nosuppressive" or "immunoprotective" properties by a mechanism other than local devices was first presented pooled and then subjected to sequential enzymatic digestion with tryspin (0.25%) and collagenase (0.2%) at by Bellgrau and Selawry (3) . They showed that when rat cryptorchid testes were successful transplanted with 37°C, as previously described (8) . Prior to the isolation of Sertoli cell aggregates, the supernatant following col-hamster islet xenografts, subsequent hamster islet transplantations either beneath the kidney capsule or in the lagenase treatment was collected and centrifuged to isolate PTC. Prior to plating, all cells were washed three liver of the host rat resulted in successful islet engraftment. Control rats, that did not first receive hamster islet times with DMEM (Gibco, BRL). Sertoli cell aggregates were plated in 150-mm cell xenografts in their cryptorchid testes, rejected the hamster islet transplants (3). They suggested, from this work, culture dishes in DMEM:F12 (Gibco, BRL) supplemented with 0.1% ITS+ (Sigma), 50 ng/ml retinol ace-that Sertoli cells induce some type of systemic tolerance in the host. However, this hypothesis has been chal-tate (Sigma), and 50 µg/ml gentamicin sulfate (Sigma), and incubated at 39°C in 5% CO 2 /95% air for 48 h to lenged. Korbutt and coworkers tested induction of immune tolerance by transplanting islet allografts and allo-expedite the removal of contaminating germ cells. These cultures then were exposed to 20 mM Tris-HCl buffer genic Sertoli cells under the rat kidney capsule (17). This was followed by removal of the grafted kidney and for 2 min to lyse remaining germ cells, washed, and returned to the CO 2 -injected incubator at 37°C in 5% the additional transplantation of rat islets in the contralateral kidney. If systemic tolerance had been induced CO 2 /95% air. Using this procedure, pretreated isolated Sertoli cell-enriched cultures (iSCs) contained greater by the initial transplant, then the subsequent islet transplants should have been accepted. This was not the case.
than 95% SCs.
Pelleted PTC, collected during the isolation proce-was used to determine differences in mean. Significance level was set at p < 0.05. dure, were plated in 150-mm cell culture dishes in DMEM:F12 supplemented with 10% fetal bovine serum
In Vivo Study (FBS, Gibco, BRL) and 50 µg/ml gentamicin sulfate and For the xenogenic skin transplantation experiment, incubated at 37°C in 5% CO 2 /95% air until confluent.
iSCs were prepared from prepubertal rats as described PTC-enriched cultures contained greater than 97% PTC.
above and injected (1 × 10 6 ) into male C57/BL6 mice Cell Transplantation. C57/BL6 (H-2b) mice were (n = 6) also as described in the in vitro studies. Four administered cell transplants in a volume of 0.5 ml C57/BL6 mice did not receive iSC injection and served sterile medium by IV injection in the lateral tail vein.
as controls. The donor skin was shaved and a full thick-Recipient mice received either suspended iSCs in the ness circular piece of skin (diameter 1 cm) was removed concentrations of 2 × 10 6 (n = 8) or PTC also in the confrom the naive rat (Sprague-Dawley) under sterile condicentrations of 2 × 10 6 (n = 8).
tions after euthanasia with CO 2 gas. A similar circular Mixed Lymphocytic Reaction (MLR). Spleens were piece of host skin was removed from the C57/BL6 harvested from animals transplanted with iSCs (n = 4) mouse and the donor skin was fitted within the wound and PTC (n = 4) (1 × 10 6 ) as well as normal C57/BL6 on the back of the host mouse. The donor rat skin was (n = 2), Balb/C mice (n = 2), and Sprague-Dawely rats sutured in place using 4-0 or 5-0 nonabsorbable suture and were used as controls. MLR was performed as pre-(Prolene) using a simple interrupted pattern. Bandages viously described (11) . Briefly, responder spleen cells were not needed. The grafts were observed daily for 4 (2 × 10 5 /100 µl) from transplanted mice were cocultured weeks. Graft rejection was defined when >50% of the with irradiated (2500 cGy) stimulator spleen cell (2 × graft showed signs of inflammation (redness, tenderness, 10 5 /100 µl) in 96-well flat-bottom plates. These cells and exudation) and scabbing. Results were expressed as also were cocultured in RPMI-1640 medium with 10% mean ± SEM. Analysis of variance was used to deter-FBS, 1% penicillin-streptomycin (Sigma) for 4 days in mine differences in the mean. Significance level was set humidified 5% CO 2 at 37°C, after which they were incuat p < 0.05. bated for 18 h with 1 µCi of [ 3 H]thymidine per well, RESULTS harvested on glass fiber papers, and [ 3 H]thymidine uptake assessed with a scintillation counter. Results were Animals were allowed to survive up to 6 months expressed as a stimulation index, calculated as the mean posttransplantation. All animals were healthy at the time of counts (three replicates) per minute (cpm) of the exof sacrifice with no signs of systemic rejection. perimental coculture divided by mean cpm of coculture SC-Transplanted Mice Are Tolerant to Xenogenic Cells with autologous cells. Mann-Whitney U-test was used A mixed lymphocytic reaction assay was used to defor nonparametric analysis. Significance level was set at termine tolerance induced by iSCs or PTC (Table 1) . p < 0.05.
Spleen cells obtained from iSC-transplanted C57/BL6 Plaque-Forming Cell (PFC) Response to In Vivo Immice were stimulated with irradiated MHC-mismatched munization With Sheep Red Blood Cells (SRBC). C57/ allogeneic Balb/c, xenogenic rat spleen cells, or syngenic BL6 mice (n = 4) transplanted with 1 × 10 6 iSCs, or 1 × C57/BL6 spleen cells (self). Spleen lymphocytes from 10 6 PTC (n = 4), and C57/BL6 nontransplanted mice C57/Bl6 mice reacted minimally to spleen cells from the (n = 2) were used for this assay (16). Briefly, mice were same stain (0.95 ± 0.19), but there was a marked reducimmunized by IP injection of 0.5 ml of 2% suspension tion in the recipient spleen T-lymphocyte response to rat of freshly collected sheep red blood cells (SRBC) in 1× spleen cells (1.87 ± 0.11) compared to control nontransphosphate-bufferd saline (PBS) (Fisher Biotech. BP661planted mice (3.43 ± 0.45). However, variability between 10, Fisher Scientific, Fair Lawn, NJ). Five days after groups prevented these differences from reaching signifimmunization, mice were euthanized and spleen cells icance. Alloreactive response to allogeneic Balb/c spleen collected for PFC assay. cells (1.7 ± 0.21) was intact and comparable to control Cytokines. Blood (0.5-1 ml) was collected in hepanontransplanted mice (1.8 ± 0.17). Spleen cells from rinized syringes from C57/BL6 mice transplanted with PTC-transplanted mice also were less reactive to rat either iSCs or PTC (1 × 10 6 cells) or normal controls.
spleen cells (1.52 ± 0.08), but maintained this low reac-Blood samples were stored on ice for 30 min, spun tivity to allogeneic Balb/c stimulation (1.4 ± 0.09). down, plasma collected, and stored at −80°C. Protein Anti-Sheep Erythrocyte (SRBC) Plaque-Forming Cell array for IL-1α, IL-1β, IL-2, IL-4, IL-6, IL-10, IL-(PFC) Assay 12p70, TNF-α, and GMCSF was done using Search-Light CCD Imaging and Analysis System (Pierce). Results
Production of humoral immune response was assayed using PFC assay, which determines primary antibody were expressed as mean ± SEM. Analysis of variance Spleen cells were collected from iSC-and PTC-transplanted mice and nontransplanted controls and cultured with irradiated cells from self, allogeneic, syngenic, and xenogenic cells to assess tolerance. Stimulator: irradiated spleen cells from transplanted, nontransplanted mice, rat spleens, iSCs, and PTC. Self: spleen cells from the same mouse. Responder: spleen cells from transplanted and nontransplanted mice. Results are reported as stimulator index (mean cpm of experimental culture divided by mean cpm of culture with autologous cells) ± SEM.
(IgM) response to SRBC (T-cell-dependent antigen). cluded IL-1α, IL-1β, IL-2, IL-4, IL-6, IL-10, IL-12p70, TNF-α, and GM-CSF, measured in pg/ml. Remarkably, Plaque formation appears as a clear zone (plaque) representing an IgM-producing plasma cell in the presence of plasma from iSC-transplanted mice showed striking decrease in expression of most of the tested cytokines with complement. The number of plaques was individually counted using a magnifying lens. C57/BL6 mice trans-the exception of TNF-α expression (12.26 ± 1.67) in iSC-transplanted mice compared to nontransplanted con-planted with (1 × 10 6 ) xenogenic rat iSCs (n = 3) ( Fig.  1) showed an increase in IgM anti-SRBC antibody re-trol (12.13). The iSC-transplanted mice showed a significant statistical difference when analyzed with ANOVA sponse (44.11 ± 5.93) compared to response in nontransplanted C57/BL6 (n = 2) mice (29.4 ± 8.13) . This in-between treatment groups [F(2) = 7.89, p = 0.0014]. Newman-Keuls post hoc analysis showed a significant crease was not specific to iSCs, because a comparable increase in anti-SRBC IgM response was similarly ob-decrease in IL-1β ( 4) , PTC-transplanted (n = 3) transplanted, and nontransplanted (n = 2) transplanted mice (312.70 ± 21.37). There was no significant change in IL-10 and IL-12 in the iSC-transplanted normal mice was examined for cytokine expression 6 weeks posttransplant (Fig. 2) . The cytokine profile in-mice compared to either nontransplanted control mice or to PTC-transplanted mice. There was no significant difference between PTC-transplanted mice and nontransplanted mice for any cytokine. IL-1α was not detected in the iSC-transplanted mice. It was unclear whether this was due to a technical error, or if IL-1α was suppressed below the limit of detectability in mice receiving iSCs. Therefore, we did not perform any comparison between groups for IL-1α. Similarly, levels of IL-4 and GM-CSF were below the limit of detectability and are not reported. mice xenogenic rat skin was significantly delayed by create this immune privileged environment. It is well known that SCs function, in part, to immunoprotect the 18.8 ± 1.79 days (p < 0.05). Nontransplanted mice showed signs of graft rejection 8 days after skin grafting highly antigenic spermatid population, which are in close contact to the SCs in situ. Reports from our re- (Fig. 3B ). However, in the iSC-transplanted group, signs of graft rejections were remarkably delayed and ranged search groups and others show that it appears likely that SCs, isolated from the prepubertal testis (iSCs), can also between 12 and 23 days after the skin graft (Fig. 3C,  D) . Nontransplanted C57/BL6 control mice received provide immunoprotection to cells other than germ cells when cotransplanted with them outside of the testis (15). syngenic C57/BL6 mouse skin as an assessment of skin grafting technique (Fig. 3A) and did not reject the This has been reported for pancreatic islets when cotransplanted with iSCs in the periphery to treat diabetes (10) syngenic mouse skin. and for neurons when cotransplanted with iSCs in the DISCUSSION brain to treat neurodegenerative diseases (4, 5, 12, 21, 24, 25, (27) (28) (29) (30) (31) (32) (38) (39) (40) . Additionally, cell transplant therapy Over the past two decades, advances in tissue and organ transplantation have revolutionized the treatment using iSCs in the 3-nitropropionic acid (3-NP) model of Huntington's disease has been shown to provide immu-of many otherwise fatal diseases such as aplastic anemia, leukemia, immune deficiencies, inborn errors of noprotective effects similar to those obtained using systemic treatments with nonsteroidal anti-inflammatory metabolism, and organ failures. However, the continued need for immune suppression to ensure long-term dura-medications (26). We have also shown, previously, that rat (allogeneic) ble engraftment has limited the widespread use of allogeneic transplantation. The brain, anterior eye chamber, or porcine (xenogenic) iSCs can survive in the rat brain without immune suppression (31) . Presumably, the non-testis, ovary, and placenta are primary immune privileged sites that protect transplanted cells from rejection antigenic iSCs prevent rejection of both allogeneic and xenogenic cell grafts due, in part, to their close proxim-(36). In the testis, it is likely that Sertoli cells (SCs) ity to the graft as is created in cotransplantation proto-C57/BL6 mice that were transplanted with rat iSCs were specifically tolerant to rat spleen cells in a mixed lym-cols (38) . However, the mechanism of immune protection by iSCs in cotransplantation is not yet clearly phocyte reaction. This tolerance was specific for donor rat cells because splenocytes from SC-transplanted mice defined and may not be limited to local effects.
Results from the current study show that systemically were properly alloreactive to MHC-mismatched Balb/c mouse spleen cells. Splenocytes from iSC-transplanted administered iSCs produce species-specific immune tolerance. SCs isolated from prepubertal rats were trans-mice produced vigorous primary antibody response to immunization with SRBCs (11) (Fig. 2) . These data con-planted, by systemic injection, into normal C57/BL6 mice without prior conditioning by immune suppression.
firm that mice transplanted with rat iSCs are immune competent and capable of eliciting proper humoral im-Isolated peritubular cells (PTCs), as well, were transplanted into the normal C57/BL6 mice as control be-mune reaction to foreign antigens, while exhibiting specific tolerance to xenogenic donor-specific antigens. cause these testicular cells are a common, but minimal, contaminant in the iSC preparation. Therefore, PTCs Pretransplantation conditioning is responsible for the majority of early fatalities in transplant patients in the were ideal to determine if the effect of iSCs on the immune system was solely a characteristic of iSCs, or if form of infection and graft versus host disease (GVHD), produced by immune-competent T-lymphocytes within PTCs, also obtained from the testis, shared this characteristic. As shown in Table 1 , spleen lymphocytes from the graft (2). When we transplanted iSCs in large num-For example, transplantation tolerance in rat recipients of intestinal allografts was improved by cotransplantation of donor strain marrow cells (20) . Donor-specific tolerance for allogeneic hepatocytes was achieved in mice transplanted with allogeneic marrow cells (45). Sertoli cells have been shown to produce tolerance at the site of injection because GFP-expressing iSCs transplanted under the kidney capsule of SCID and Balb/c mice promoted islet engraftment at both 30 and 60 days posttransplantation (9) .
To determine whether the immune tolerizing effect of systemic administration of iSCs could be extended to an in vivo situation, rat skin grafts were transplanted into naive mice and into mice transplanted with iSCs. Delayed rejection of the skin grafts in the iSC-transplanted groups confirms that the immune tolerance achieved by systemic administration of iSCs may have clinical applications and allow acceptance of other organs and tissue grafts. In this study, xengenic skin graft cause eventually all skin grafts were rejected, systemic administration of iSCs could be considered highly promising when compared to other tolerizing forms of cell therapy like bone marrow transplantation (1). Achieving bers (1 × 10 6 cells), crossing the rat-mouse xenogenic barrier, no immune suppression was required prior to long-lasting durable tolerance may necessitate manipulating factors like modifying the dose of iSCs, or re-transplantation. The mice were healthy and showed no signs of GVHD, which is usually induced by other peated injections of iSCs. The systemic effects of Sertoli cells, as shown in this forms of toleralizing cell therapy regimens such as bone marrow transplantation (13, 22) . report, suggest that systemically injected iSCs induce tolerance to donor-type cells in the host mouse, which In marrow transplant chimeras, donor T-cell production is critical for maintenance of long-term transplanta-is consistent with a similar conclusion by Bellgrau and coworkers (3) but inconsistent with a report to the con-tion tolerance (42) . Tolerance induction by systemic administration of iSCs could be attributed to various trary by Korbuttt and coworkers (17). The latter authors suggested that iSCs could not induce tolerance to trans-mechanisms. One such mechanism may involve cytokines and soluble mediators. In transplantation models, planted islets in the diabetic rat. It is difficult to compare and contrast the results of our project to those of Bell-Th1 cytokine profile is usually associated with allograft rejection, while Th2 cytokine profile is associated with grau and Korbutt in that the iSCs in their projects were not transplanted by systemic injection nor were assays transplantation tolerance. However, recent data suggest that this paradigm may be reversed where in vivo ad-of systemic immune modulation reported, as is the case in the current report. It is clear that cotransplantation of ministration of Th2 cytokines stimulated allograft rejection (47). Cytokine profile expression shown in Figure  islets and iSCs under the kidney capsule did not allow for immune acceptance of islets transplanted in the con-2 demonstrates a marked suppression in the inflammatory Th1 cytokine profile (IL-1, IL-2, IL-6, and TNF-tralateral kidney (17), indicating the absence of induced tolerance by the initial graft. It is possible, however, that α), but also suppression of IL-10, and Th2 regulatory cytokine. Additional analysis of some key Th2 regulator the number of transplanted iSCs and their isolation in the kidney did not provide for enough systemic exposure cytokines like IL-4 is required. Nonetheless, the highly significant suppression of various inflammatory cytokines to induce tolerization by iSCs and that the absence of islet rejection was the result of local immunoprotection, suggests that the CD4 population, especially the Th1 subpopulation, is dramatically modulated by IV admin-as suggested by others. In this sense, our results may not be in conflict with those of Korbutt and coworkers (17), istration of Sertoli cells isolated from the prebubertal rat.
Transplantation tolerance induced by other forms of but may instead indicate additional systemic immune modulatory capabilities of iSCs, as originally suggested cell therapy like bone marrow transplantation promotes desirable acceptance of donor tissues and organ grafts. 
